Which Diabetes Patients Will Benefit the Most from Once-Weekly Basal Insulin Analogs? A Review with a Special Focus on Type 1 Diabetes Patients. - Kosmeri, Chrysoula; Baltogianni, Maria; Giapros, Vasileios; Siomou, Ekaterini; Tsinopoulou, Vasiliki-Regina; Balomenou, Foteini; Serbis, Anastasios (Endocrines, 2024)